Xenon Pharmaceuticals (XENE) Stock News
$XENE · NASDAQ · 2 stories in 30 daysBORSA has published 2 stories on Xenon Pharmaceuticals (XENE) in the past 30 days. BORSA’s news read on XENE is bullish at 63/100, unchanged over 24 hours, based on 2 company events over the past 30 days. XENE last closed at $34.42 on Oct 13, down 5.88% over five sessions and down 40.85% over the past month. Xenon Pharmaceuticals’ next earnings report is scheduled for Monday, Nov 2.
The wire on $XENE
newest first · updated · direct subject stories onlyGuggenheim resumes Xenon Pharmaceuticals coverage with Buy, $73 target
Guggenheim resumed coverage of Xenon Pharmaceuticals (XENE) with a Buy rating and a $73 price target.
bullish 70 · impact 40